Euglena Co., Ltd. (FRA:8EG)

Market Cap	301.89M
Revenue (ttm)	284.68M
Net Income (ttm)	103.67K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	2,912.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.180
Previous Close	2.280
Day's Range	2.180 - 2.180
52-Week Range	2.180 - 3.280
Beta	n/a
RSI	31.00
Earnings Date	Feb 10, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, and midori koji; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorpor...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 897
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8EG

Financial Performance

In 2024, Euglena's revenue was 47.62 billion, an increase of 2.44% compared to the previous year's 46.48 billion. Losses were -650.00 million, -75.49% less than in 2023.

Financial numbers in JPY